2025年全球鼻腔给药装置市场报告

预计未来几年鼻腔给药装置市场规模将强劲成长。到 2029 年，这一数字将成长至 920.5 亿美元，年复合成长率（CAGR）为 8.8%。预测期内的成长可归因于老年人口的成长、全球呼吸问题的增加、神经系统疾病应用的扩大、个人化医疗的趋势、预防性医疗保健的努力以及新兴国家的市场渗透。预测期内的主要趋势包括配方技术的进步、对儿科和老年应用的关注、自我给药装置的兴起、鼻粉吸入器以及生技药品和胜肽的结合。

预计未来几年慢性病盛行率的上升将推动鼻腔给药装置市场的成长。慢性病是指持续时间超过一年且需要持续治疗、限制日常活动或两者兼而有之的疾病。鼻腔给药装置透过提供一种非侵入性且有效的给药方法来治疗慢性疾病。该装置可将药物直接输送到目标部位，方便、易用且吸收迅速。例如，2024 年 6 月，英国政府机构国家医疗服务体系 (NHS) 报告称，2023 年，英格兰将有超过 50 万名（549,000）新人被确诊患有第 2 型糖尿病。这使在全科医生处登记的非糖尿病性高血糖或糖尿病前期患者总数达到 3,615,330 人，与 2022 年的 3,065,825 人相比大幅增加，增幅接近 20%。因此，慢性病盛行率的不断上升正在推动鼻腔给药装置市场的扩张。

此外，对非侵入性药物输送方法的需求不断增长也有望促进鼻腔药物输送装置市场的扩张。非侵入性药物输送涉及将药物输送到体内，而无需穿透或切开皮肤或黏膜。鼻腔给药装置在促进这种方法并使鼻腔给药简单有效方面发挥了关键作用。这些装置利用鼻腔广泛的血管网络并确保快速吸收，从而提高药物的生物有效性，改善患者的依从性并消除侵入性手术的需要。例如，美国美容协会 2023 年 8 月发布的资料显示，美国非手术治疗数量显着增加，2022 年身体塑形、皮肤护理、毒素和微针疗法的成长率分别为 31%、26%、24% 和 23%。因此，对非侵入性药物输送方法的需求不断增长是鼻腔药物输送装置市场扩张的主要驱动力。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场－宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球鼻腔给药装置 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
• 最终用途产业分析
• 全球鼻腔给药装置市场：成长率分析
• 全球鼻腔给药装置市场表现：规模与成长，2019-2024
• 全球鼻腔给药装置市场预测：规模与成长，2024-2029 年，2034 年
• 全球鼻腔给药装置总目标市场（TAM）

第六章市场区隔

• 全球鼻腔给药装置市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 送粉装置
• 供液单元
• 加压定量吸入器
• 其他产品
• 全球鼻腔给药装置市场（依剂量、实际及预测），2019-2024 年、2024-2029 年、2034 年
• 单位剂量
• 多剂量
• 全球鼻腔给药装置市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 慢性阻塞性肺病（COPD）
• 鼻炎
• 囊肿纤维化
• 鼻塞
• 气喘
• 其他用途
• 全球鼻腔给药装置市场：依最终用户、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 医院
• 诊所
• 居家护理
• 其他最终用户
• 全球鼻腔给药装置市场，粉末给药装置细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 单剂量粉末装置
• 多剂量粉末装置
• 全球鼻腔给药装置市场、液体输送装置细分市场、类型、性能及预测（2019-2024 年、2024-2029 年及 2034 年）
• 单剂量液体装置
• 多剂量液体装置
• 全球鼻腔给药装置市场压力定量喷雾吸入器（pMDI）细分市场按类型、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 呼吸激活PMDI
• 常规pMDI
• 全球鼻腔给药装置市场及其他产品细分市场，依类型、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 凝胶输送装置
• 喷雾器
• 鼻喷剂

第七章 区域和国家分析

• 全球鼻腔给药装置市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球鼻腔给药装置市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 鼻腔给药装置市场：竞争格局
• 鼻腔给药装置市场：公司简介
  • Johnson and Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• 3M Company
• Becton, Dickinson and Company
• Teva Pharmaceutical Industries Ltd.
• AptarGroup Inc.
• West Pharmaceutical Services Inc.
• Teleflex Incorporated
• Recipharm AB
• Nemera Development SA
• Consort Medical plc.
• Vectura Group plc
• Douglas Pharmaceuticals Ltd.
• Avanir Pharmaceuticals
• OptiNoset Inc.
• Flamel Technologies
• Aegis Therapeutics LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年鼻腔给药装置市场：提供新机会的国家
• 2029年鼻腔给药装置市场：细分市场带来新机会
• 2029年鼻腔给药装置市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Intranasal drug delivery devices are medical instruments designed to administer medications into the nasal cavity. These devices are specifically created to deliver medications directly to the highly vascularized nasal mucosa, which boasts a substantial surface area, facilitating rapid absorption of the drug into the bloodstream. Intranasal drug delivery devices are capable of delivering drugs or therapeutic substances in various forms, including sprays, powders, or liquid solutions, directly into the nasal cavity.

The primary products within the realm of intranasal drug delivery devices include powder delivery devices, liquid delivery devices, pressurized metered-dose inhalers, and other related devices. Powder delivery devices, a subtype of medical or pharmaceutical devices, are designed for administering medications in unit-dose or multi-dose forms and find applications in various medical conditions such as chronic obstructive pulmonary disease (COPD), rhinitis, cystic fibrosis, nasal congestion, asthma, among others. The end users of these devices include hospitals, clinics, homecare, and other healthcare settings.

The intranasal drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides intranasal drug delivery devices market statistics, including intranasal drug delivery devices industry global market size, regional shares, competitors with a intranasal drug delivery devices market share, detailed intranasal drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the intranasal drug delivery devices industry. This intranasal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intranasal drug delivery devices market size has grown strongly in recent years. It will grow from $60.27 billion in 2024 to $65.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rise in chronic respiratory diseases, patient preference and compliance, convenience in self-administration, pediatric applications, market expansion in allergic rhinitis treatment, wider range of indications.

The intranasal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $92.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing geriatric population, rising global respiratory issues, expanding applications in neurological disorders, personalized medicine trends, preventive healthcare initiatives, market penetration in emerging economies. Major trends in the forecast period include advances in formulation technologies, focus on pediatric and geriatric applications, rise in self-administration devices, nasal powder inhalers, incorporation of biologics and peptides.

The rising incidence of chronic diseases is anticipated to drive the growth of the intranasal drug delivery devices market in the coming years. Chronic diseases are defined as conditions lasting one year or more that require ongoing medical care, restrict daily activities, or both. Intranasal drug delivery devices are employed to manage chronic diseases by providing a non-invasive and effective means of administering medications. These devices enable medications to be delivered directly to the targeted area, offering convenience, ease of use, and promoting rapid absorption. For example, in June 2024, the National Health Service (NHS), a UK-based government agency, reported that in 2023, over half a million (549,000) additional individuals in England were identified as being at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a general practitioner to 3,615,330, marking a significant increase from 3,065,825 in 2022 and representing nearly a 20% rise. Therefore, the growing prevalence of chronic diseases is fueling the expansion of the intranasal drug delivery devices market.

The growing demand for non-invasive drug delivery methods is also expected to contribute to the expansion of the intranasal drug delivery device market. Non-invasive drug delivery involves administering pharmaceutical substances into the body without the need for skin or mucous membrane penetration or incision. Intranasal drug delivery devices play a crucial role in facilitating this approach, making it easy and effective to administer drugs through the nose. Leveraging the nose's extensive blood vessel network and ensuring fast absorption, these devices enhance drug bioavailability, improve patient adherence, and eliminate the need for invasive procedures. For example, data from The Aesthetic Society in August 2023 highlighted a significant increase in nonsurgical procedures in the U.S., with body contouring, skin treatment, toxins, and micro-needling showing growth rates of 31%, 26%, 24%, and 23%, respectively, in 2022. As a result, the growing demand for non-invasive drug delivery methods is a key driver for the expansion of the intranasal drug delivery device market.

Major pharmaceutical companies in the nasal drug delivery technology market are actively engaged in developing new and improved products to offer innovative drug administration methods and maintain their market position. For instance, in January 2023, AptarGroup, Inc., a US-based drug delivery and pharmaceutical company, introduced APF Futurity, the first recyclable, metal-free, multidose nasal spray for delivering nasal saline and similar over-the-counter (OTC) formulations. This product, made from polyolefin materials and devoid of metal components or recycling disruptors, reduces the need for separation in recycling streams and supports a higher grade of recycled materials. Notably, APF Futurity is a highly recyclable nasal spray pump that has obtained Class AA certification from cyclos-HTP for recycling streams in Europe.

In March 2022, Sandoz AG, a Switzerland-based biopharmaceutical company under the Novartis Group, acquired Coalesce Product Development Limited for an undisclosed amount. This strategic move aims to enhance Sandoz's capabilities in inhalation drug delivery, add a commercial-stage product to its portfolio, and expedite the development and commercialization of intranasal drug delivery devices. Coalesce Product Development Limited, based in the UK, specializes in drug delivery device development, including nasal drug delivery.

Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation

North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intranasal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The intranasal drug delivery devices market consists of sales of nasal sprays, nasal powder devices, nasal antipsychotic medications, nasal epinephrine devices, nasal drops, and nasal inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intranasal Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intranasal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intranasal drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intranasal drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Powder Delivery Device; Liquid Delivery Device; Pressurized Metered-Dose Inhalers; Other Products
• 2) By Dosage: Unit-Dose; Multi-Dose
• 3) By Application: Chronic Obstructive Pulmonary Disease (COPD); Rhinitis; Cystic Fibrosis; Nasal Congestion; Asthma; Other Applications
• 4) By End User: Hospitals; Clinics; Homecare; Other End Users
• Subsegments:
• 1) By Powder Delivery Device: Single-Dose Powder Device; Multi-Dose Powder Device
• 2) By Liquid Delivery Device: Single-Dose Liquid Device; Multi-Dose Liquid Device
• 3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs; Conventional pMDIs
• 4) By Other Products: Gel Delivery Device; Nebulizers; Nasal Sprays
• Companies Mentioned: Johnson and Johnson Inc.; Merck and Co.Inc.; Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intranasal Drug Delivery Devices Market Characteristics

3. Intranasal Drug Delivery Devices Market Trends And Strategies

4. Intranasal Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Intranasal Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Intranasal Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Intranasal Drug Delivery Devices Market Growth Rate Analysis
• 5.4. Global Intranasal Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Intranasal Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Intranasal Drug Delivery Devices Total Addressable Market (TAM)

6. Intranasal Drug Delivery Devices Market Segmentation

• 6.1. Global Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Powder Delivery Device
• Liquid Delivery Device
• Pressurized Metered-Dose Inhalers
• Other Products
• 6.2. Global Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Unit-Dose
• Multi-Dose
• 6.3. Global Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Obstructive Pulmonary Disease (COPD)
• Rhinitis
• Cystic Fibrosis
• Nasal Congestion
• Asthma
• Other Applications
• 6.4. Global Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare
• Other End Users
• 6.5. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Powder Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Powder Device
• Multi-Dose Powder Device
• 6.6. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Liquid Delivery Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Liquid Device
• Multi-Dose Liquid Device
• 6.7. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Pressurized Metered-Dose Inhalers (pMDIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breath-Actuated PMDIs
• Conventional pMDIs
• 6.8. Global Intranasal Drug Delivery Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gel Delivery Device
• Nebulizers
• Nasal Sprays

7. Intranasal Drug Delivery Devices Market Regional And Country Analysis

• 7.1. Global Intranasal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Intranasal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intranasal Drug Delivery Devices Market

• 8.1. Asia-Pacific Intranasal Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intranasal Drug Delivery Devices Market

• 9.1. China Intranasal Drug Delivery Devices Market Overview
• 9.2. China Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intranasal Drug Delivery Devices Market

• 10.1. India Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intranasal Drug Delivery Devices Market

• 11.1. Japan Intranasal Drug Delivery Devices Market Overview
• 11.2. Japan Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intranasal Drug Delivery Devices Market

• 12.1. Australia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intranasal Drug Delivery Devices Market

• 13.1. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intranasal Drug Delivery Devices Market

• 14.1. South Korea Intranasal Drug Delivery Devices Market Overview
• 14.2. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intranasal Drug Delivery Devices Market

• 15.1. Western Europe Intranasal Drug Delivery Devices Market Overview
• 15.2. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intranasal Drug Delivery Devices Market

• 16.1. UK Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intranasal Drug Delivery Devices Market

• 17.1. Germany Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intranasal Drug Delivery Devices Market

• 18.1. France Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intranasal Drug Delivery Devices Market

• 19.1. Italy Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intranasal Drug Delivery Devices Market

• 20.1. Spain Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intranasal Drug Delivery Devices Market

• 21.1. Eastern Europe Intranasal Drug Delivery Devices Market Overview
• 21.2. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intranasal Drug Delivery Devices Market

• 22.1. Russia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intranasal Drug Delivery Devices Market

• 23.1. North America Intranasal Drug Delivery Devices Market Overview
• 23.2. North America Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intranasal Drug Delivery Devices Market

• 24.1. USA Intranasal Drug Delivery Devices Market Overview
• 24.2. USA Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intranasal Drug Delivery Devices Market

• 25.1. Canada Intranasal Drug Delivery Devices Market Overview
• 25.2. Canada Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intranasal Drug Delivery Devices Market

• 26.1. South America Intranasal Drug Delivery Devices Market Overview
• 26.2. South America Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intranasal Drug Delivery Devices Market

• 27.1. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intranasal Drug Delivery Devices Market

• 28.1. Middle East Intranasal Drug Delivery Devices Market Overview
• 28.2. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intranasal Drug Delivery Devices Market

• 29.1. Africa Intranasal Drug Delivery Devices Market Overview
• 29.2. Africa Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intranasal Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Intranasal Drug Delivery Devices Market Competitive Landscape
• 30.2. Intranasal Drug Delivery Devices Market Company Profiles
  • 30.2.1. Johnson and Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

31. Intranasal Drug Delivery Devices Market Other Major And Innovative Companies

• 31.1. 3M Company
• 31.2. Becton, Dickinson and Company
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. AptarGroup Inc.
• 31.5. West Pharmaceutical Services Inc.
• 31.6. Teleflex Incorporated
• 31.7. Recipharm AB
• 31.8. Nemera Development S.A.
• 31.9. Consort Medical plc.
• 31.10. Vectura Group plc
• 31.11. Douglas Pharmaceuticals Ltd.
• 31.12. Avanir Pharmaceuticals
• 31.13. OptiNoset Inc.
• 31.14. Flamel Technologies
• 31.15. Aegis Therapeutics LLC

32. Global Intranasal Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intranasal Drug Delivery Devices Market

34. Recent Developments In The Intranasal Drug Delivery Devices Market

35. Intranasal Drug Delivery Devices Market High Potential Countries, Segments and Strategies

• 35.1 Intranasal Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Intranasal Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Intranasal Drug Delivery Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer